Learn more
Join Dexa

Chasing HDL: Insights and Discoveries

Thomas and Peter discuss the challenges of treating dysfunctional HDL and the potential benefits of a drug that depletes HDL cholesterol, offering insights into the regulation of the scavenger receptor and its impact on coronary health.
  • In this clip

  • From this podcast

    The Peter Attia Drive Podcast avatar

    The Peter Attia Drive Podcast

    #22 – Tom Dayspring Part III of V: reverse cholesterol transport, CETP inhibitors, & apolipoproteins

  • Related Questions

    • What does Peter Attia say about ApoB and how it can be pharmacologically reduced in the episode Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity | Huberman Lab Podcast #85 and the clip Lowering Cholesterol?

    • What does Peter Attia say about ApoB and how it can be pharmacologically reduced in the episode Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity | Huberman Lab Podcast #85 and the clip Lowering Cholesterol?

Built by
Charlie AI
© 2024 DexaPressTermsPrivacySupport